All articles tagged with #compounding
Novo Nordisk filed a lawsuit seeking a permanent ban and damages against Hims & Hers for allegedly selling compounded, patent-infringing versions of Wegovy (semaglutide); Hims paused its obesity-pill copycat after regulatory scrutiny as FDA actions loom, underscoring a broader crackdown on compounded GLP-1 drugs used by as many as 1.5 million Americans amid intense obesity-drug competition.
A lawsuit filed by Strive Specialties alleges Eli Lilly and Novo Nordisk blocked telehealth partners to curb compounded GLP-1 therapies, potentially impacting about 1.5 million U.S. patients who rely on cheaper, personalized versions of Wegovy/Ozempic. The plaintiffs say these agreements limit prescriber choice and patient access, while the drugmakers argue the deals target mass-produced copies. Novo Nordisk has highlighted the past Hims & Hers partnership ended after compounded Wegovy issues, and Lilly labeled the suit a bid to divert attention from Strive’s own conduct. The case underscores ongoing tensions between compounded vs. branded GLP-1 drugs, access, and pricing in the weight‑loss market.
Warren Buffett recommends investing in the Vanguard S&P 500 ETF as a low-cost, diversified way to benefit from the long-term growth of American companies, suggesting that a monthly $300 investment could grow to $1 million over 35 years through the power of compounding.
Hims & Hers Health plans to continue making cheaper, compounded versions of Novo Nordisk's weight-loss drug Wegovy despite Novo ending their partnership and accusing the company of legal violations. The CEO emphasized their commitment to patient choice and independence from pharmaceutical pressure, even as legal and regulatory challenges persist.
Investing $5,000 in a 6-month certificate of deposit (CD) can lock in current interest rates, which are influenced by the Federal Reserve's rate decisions. With rates currently declining, locking in a CD rate can be beneficial. Interest on CDs is compounded monthly, enhancing earnings over time. For example, at a 4.43% rate, a $5,000 investment could earn approximately $111.77 in six months. CDs offer a secure, passive income option, but it's important to understand terms and potential penalties for early withdrawal.
Warren Buffett warns against the dangers of leverage, cautioning that it can lead even the smartest investors to financial ruin. This applies to dividend investing as well, as excessive reliance on debt can undermine the stability and growth of a company's dividend. Prudent balance sheet management is crucial for dividend investors, and examples of companies with attractive yields and strong balance sheets include Enterprise Products Partners, Realty Income, and Brookfield Infrastructure. Smart investors should prioritize slow and steady compounding over the allure of quick gains through leverage, as the long-term rewards of value investing and dividend compounding are substantial and attainable.
Charlie Munger, billionaire investor and business partner of Warren Buffett, emphasizes the importance of patience in investing, stating that "the big money is not in the buying and the selling but in the waiting." This highlights the power of compounding, where reinvesting returns over time can lead to exponential growth. Munger's insight challenges the misconception that high returns require high effort, emphasizing the value of a well-thought-out strategy and patience. He also demonstrates his commitment to philanthropy through a recent donation to an art museum, highlighting the importance of art as an investment.